Genentech Disappointed With FDA Panel Vote For Revoking Avastin Approval – RTT News

Posted by on Jun 30th, 2011 and filed under Medical News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Genentech Disappointed With FDA Panel Vote For Revoking Avastin Approval – RTT News


ABC News

Genentech Disappointed With FDA Panel Vote For Revoking Avastin Approval
RTT News
(RTTNews) – Genentech, a unit of Swiss drugmaker Roche Holding AG (RHHBY.PK: News ) said Wednesday that it was disappointed with the US Food and Drug Administration advisory panels decision to recommend that the regulatory body withdraw its approval of
FDA advisors reject Avastin as breast cancer treatmentLos Angeles Times
FDA panel against use of Avastin for breast cancerSan Francisco Chronicle
One patient's plea for FDA approval of AvastinWHTC
ABC News –The Takeaway –KVOA Tucson News
all 960 news articles »

Leave a Reply

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.